1-4 of 4
Donna M. Weber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma

Krina K. Patel, Jatin J. Shah, Lei Feng, Hans C. Lee, Elisabet M. Manasanch, Jasper Olsem, Ashley Morphey, Xiao Jiao Huo, Sheeba K. Thomas, Qaiser Bashir, Muzaffar H. Qazilbash, Donna M. Weber, Robert Z. Orlowski
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1277–1284.
https://doi.org/10.1158/1078-0432.CCR-21-3420
Published: 01 April 2022
View article titled, Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma
Open the PDF for Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma in another window
Includes: Supplementary data
Journal Articles

Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis

Neeraj Saini, Junsheng Ma, Denái R. Milton, Romil Patel, Ankur Varma, Qaiser Bashir, Ruby Delgado, Akash Mukherjee, Gabriela Rondon, Uday R. Popat, Chitra M. Hosing, Yago Nieto, Partow Kebriaei, Amin M. Alousi, Sairah Ahmed, Guilin Tang, Rohtesh Mehta, Samer Srour, Issa F. Khouri, Swaminathan Iyer, Donna M. Weber, Sheeba K. Thomas, Hans C. Lee, Elisabet E. Manasanch, Krina K. Patel, Robert Z. Orlowski, Richard E. Champlin, Muzaffar H. Qazilbash
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22): 6781–6787.
https://doi.org/10.1158/1078-0432.CCR-19-0706
Published: 15 November 2019
View article titled, Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
Open the PDF for Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis in another window
Includes: Supplementary data
Journal Articles

Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression

Richard J. Jones, Tawin Iempridee, Xiaobin Wang, Hans C. Lee, Janet E. Mertz, Shannon C. Kenney, Heather C. Lin, Veerabhadran Baladandayuthapani, Christopher W. Dawson, Jatin J. Shah, Donna M. Weber, Robert Z. Orlowski
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19): 4901–4912.
https://doi.org/10.1158/1078-0432.CCR-15-2242
Published: 02 October 2016
View article titled, Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression
Open the PDF for Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein–Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression in another window
Includes: Supplementary data
Journal Articles

Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia

Isere Kuiatse, Veerabhadran Baladandayuthapani, Heather Y. Lin, Sheeba K. Thomas, Chad C. Bjorklund, Donna M. Weber, Michael Wang, Jatin J. Shah, Xing-Ding Zhang, Richard J. Jones, Stephen M. Ansell, Guang Yang, Steven P. Treon, Robert Z. Orlowski
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2538–2545.
https://doi.org/10.1158/1078-0432.CCR-14-1462
Published: 31 May 2015
View article titled, Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia
Open the PDF for Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia in another window
Includes: Supplementary data